Nitazoxanide 500Mg Oral Tablet

DRUG5 trials

Conditions

Coronavirus InfectionHelminth InfectionIrritable Bowel Syndrome With DiarrheaProtozoan InfectionsRheumatoid ArthritisSexually Transmitted DiseasesUlcerative ColitisUlcerative Colitis Exacerbation

Phase 1

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

NCT03441893

Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanHelminth Infection, Protozoan Infections, Ulcerative Colitis +1

Start: 2015-01-01End: 2025-12-31Target: 300Updated: 2023-03-03

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

WithdrawnNCT05453916

Sadat City UniversityIrritable Bowel Syndrome With Diarrhea

Start: 2022-07-01End: 2024-12-31Updated: 2025-07-14

Phase 2

Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Not yet recruitingNCT05897034

Tanta UniversitySexually Transmitted Diseases

Start: 2023-06-20End: 2028-06-20Target: 100Updated: 2023-06-12

Phase 3

Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

CompletedNCT05480878

Tanta UniversityRheumatoid Arthritis

Start: 2022-12-02End: 2023-04-01Updated: 2023-04-25

Phase 4

Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

CompletedNCT04406246

Materno-Perinatal Hospital of the State of MexicoCoronavirus Infection

Start: 2020-05-21End: 2020-12-31Updated: 2021-03-30

Related Papers

Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.

2021-06-2749 citations